JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB155078

Anti-CKS2 antibody [EPR7946(2)]

4

(1 Review)

|

(17 Publications)

Rabbit Recombinant Monoclonal CKS2 antibody. Suitable for WB and reacts with Human samples. Cited in 17 publications.

View Alternative Names

Cyclin-dependent kinases regulatory subunit 2, CKS-2, CKS2

1 Images
Western blot - Anti-CKS2 antibody [EPR7946(2)] (AB155078)
  • WB

Unknown

Western blot - Anti-CKS2 antibody [EPR7946(2)] (AB155078)

All lanes:

Western blot - Anti-CKS2 antibody [EPR7946(2)] (ab155078) at 1/1000 dilution

Lane 1:

Caco-2 cell lysate at 10 µg

Lane 2:

293T cell lysate at 10 µg

Lane 3:

MOLT4 cell lysate at 10 µg

Predicted band size: 10 kDa

false

  • Carrier free

    Rabbit IgG, polyclonal - Isotype Control (Low Endotoxin, Azide-Free)

  • Unconjugated

    Rabbit IgG, polyclonal - Isotype Control

  • Unconjugated

    Rabbit F(ab')2 IgG - Isotype Control

  • 702 Alexa Fluor® 680

    Donkey Anti-Rabbit IgG H&L (Alexa Fluor® 680)

  • 775 Alexa Fluor® 750

    Goat Anti-Rabbit IgG H&L (Alexa Fluor® 750) preadsorbed

  • 775 Alexa Fluor® 750

    Goat Anti-Rabbit IgG Fc (Alexa Fluor® 750)

  • 805 Alexa Fluor® 790

    Donkey Anti-Rabbit IgG H&L (Alexa Fluor® 790) preadsorbed

  • HRP

    Goat Anti-Rabbit IgG H&L (HRP)

  • HRP

    VHH Single Domain Anti-Rabbit IgG Fc (HRP)

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR7946(2)

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Drosophila melanogaster": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Binds to the catalytic subunit of the cyclin dependent kinases and is essential for their biological function.
See full target information CKS2

Publications (17)

Recent publications for all applications. Explore the full list and refine your search

Translational cancer research 14:5045-5058 PubMed40950663

2025

Facilitation of natural killer T-cell cytotoxic activity in uterine sarcoma via the axis.

Applications

Unspecified application

Species

Unspecified reactive species

Yali Du,Ting Lan,Mengyuan Liu,Weiyan Wu,Jinqi Ma

BMC cancer 25:1182 PubMed40676553

2025

DNMT1 blocks SOX21-repressed CKS2 transcription to promote gastric cancer progression.

Applications

Unspecified application

Species

Unspecified reactive species

Jie Wei,Song Xue,Xinglong Du,Yuanfei Dai,Yuting Ji,Guangsi He

Cancer medicine 13:e70435 PubMed39560180

2024

Unveiling CKS2: A Key Player in Aggressive B-Cell Lymphoma Progression and a Target for Synergistic Therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Fenling Zhou,Lu Chen,Zhen Liu,Yuli Cao,Cuilan Deng,Gexiu Liu,Chengcheng Liu

Translational oncology 47:102042 PubMed38924847

2024

Integrated analysis of histone modification features in clear cell renal cancer for risk stratification and therapeutic prediction.

Applications

Unspecified application

Species

Unspecified reactive species

Wenming Ma,Qintao Ge,Yu Guan,Li Zhang,Liqun Huang,Lei Chen,Wenlong Xu,Jialin Meng,Guosheng Yang,Chaozhao Liang

Vascular medicine (London, England) 29:369-380 PubMed38623630

2024

Alleviating iatrogenic effects of paclitaxel via antiinflammatory treatment.

Applications

Unspecified application

Species

Unspecified reactive species

Mengwei Zhang,Saran Lotfollahzadeh,Nagla Elzinad,Xiaosheng Yang,Murad Elsadawi,Adam C Gower,Mostafa Belghasem,Tarek Shazly,Vijaya B Kolachalama,Vipul C Chitalia

Journal of hepatocellular carcinoma 10:1767-1784 PubMed37841370

2023

Expression of CKS2 in Hepatocellular Carcinoma: Correlation with Survival Outcomes and Immune Microenvironment.

Applications

Unspecified application

Species

Unspecified reactive species

Renhou Zhi,Pengfei Hao,Weibin Li,Haoliang Zhao

Translational cancer research 12:2276-2293 PubMed37859732

2023

Identification of as a novel prognostic biomarker and potential therapeutic target for oral squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Danqi Qiu,Hongshi Cai,Jianfeng Liang,Ziyi Wang,Fan Song,Yaoqi Jiang,Rukeng Tan,Jingsong Hou

Cell death & disease 13:784 PubMed36096885

2022

E2F1/CKS2/PTEN signaling axis regulates malignant phenotypes in pediatric retinoblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Meng Chen,Zhaozhao Zhao,Lianqun Wu,Jiancheng Huang,Peng Yu,Jiang Qian,Ting Ni,Chen Zhao

Drug development research 83:1589-1599 PubMed35903032

2022

Knockdown of replication protein A 3 induces protective autophagy and enhances cisplatin sensitivity in lung adenocarcinoma by inhibiting AKT/mTOR signaling via binding to cyclin-dependent kinases regulatory subunit 2.

Applications

Unspecified application

Species

Unspecified reactive species

Lijun Chen,Ke Hu,Yu Liu,Lingli Liu,Juanjuan Tang,Xiaobing Qin

International journal of oncology 60: PubMed35059737

2022

Overexpression of Parkin in clear cell renal cell carcinoma decreases tumor aggressiveness by regulating CKS2 levels.

Applications

Unspecified application

Species

Unspecified reactive species

Laura Kristin Esser,Vittorio Branchi,Farhad Shakeri,Adrian Georg Simon,Carsten Stephan,Glen Kristiansen,Andreas Buness,Hubert Schorle,Marieta Ioana Toma
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com